Comparison of Measured and Estimated GFR for Rivaroxaban Dosing in Hospitalized Older Adults
Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Standard
Comparison of Measured and Estimated GFR for Rivaroxaban Dosing in Hospitalized Older Adults. / Iversen, Esben; Hornum, Mads; Houlind, Morten Baltzer.
I: American Journal of Kidney Diseases, Bind 83, Nr. 1, 2023, s. 117-118.Publikation: Bidrag til tidsskrift › Letter › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Comparison of Measured and Estimated GFR for Rivaroxaban Dosing in Hospitalized Older Adults
AU - Iversen, Esben
AU - Hornum, Mads
AU - Houlind, Morten Baltzer
N1 - Funding Information: The authors declare that they have no relevant financial interests. Received May 3, 2023. Direct editorial input from an Associate Editor and a Deputy Editor. Accepted in revised form July 15, 2023.
PY - 2023
Y1 - 2023
N2 - Lyu et al1 evaluated discrepancies between different glomerular filtration rate (GFR) estimating equations among 30,261 patients with atrial fibrillation. In patients with low body mass index (BMI), they observed that GFR was lowest according to estimated creatinine clearance (eCrCl), highest according to estimated GFR (eGFR) indexed to body surface area, and intermediate according to nonindexed eGFR. In patients with high BMI, they observed the opposite trend. However, this conclusion is a mathematical consequence of the equations themselves and does not require any analysis of patient data.2
AB - Lyu et al1 evaluated discrepancies between different glomerular filtration rate (GFR) estimating equations among 30,261 patients with atrial fibrillation. In patients with low body mass index (BMI), they observed that GFR was lowest according to estimated creatinine clearance (eCrCl), highest according to estimated GFR (eGFR) indexed to body surface area, and intermediate according to nonindexed eGFR. In patients with high BMI, they observed the opposite trend. However, this conclusion is a mathematical consequence of the equations themselves and does not require any analysis of patient data.2
U2 - 10.1053/j.ajkd.2023.07.010
DO - 10.1053/j.ajkd.2023.07.010
M3 - Letter
C2 - 37678741
AN - SCOPUS:85176226856
VL - 83
SP - 117
EP - 118
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
SN - 0272-6386
IS - 1
ER -
ID: 374303735